Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non-small cell lung cancer patients.

Ayako ShionoKyoichi KairaAtsuto MouriOu YamaguchiKosuke HashimotoTakahiro UchidaYu MiuraFuyumi NishiharaYoshitake MurayamaKunihiko KobayashiHiroshi Kagamu

Published in: Thoracic cancer (2019)

Ramucirumab plus docetaxel achieved a higher response rate when administered immediately after nivolumab failure compared to regimens without prior nivolumab administration.

Keyphrases

single cell
locally advanced
cell therapy
stem cells
radiation therapy